Emily English

Emily P. English, PhD, RAC, is Director of Quality at Cartesian Therapeutics, a clinical-stage biopharmaceutical company that is pioneering RNA cell therapy in and beyond oncology. Prior to Cartesian, Dr. English led the life sciences portfolio in a Baltimore family office. She was previously the CEO of Gemstone Biotherapeutics, a regenerative medicine spinout from Johns Hopkins University, where she started her career as a scientist and program manager at the JHU Applied Physics Laboratory. She holds a Ph.D. in chemistry from the University of Wisconsin, Madison. Outside of work, Dr. English enjoys spending time with her family, and she is an avid curler